State Street’s Tempest Therapeutics TPST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,192
| Closed | -$30.6K | – | 4320 |
|
|
2025
Q1 | $30.6K | Hold |
3,192
| – | – | ﹤0.01% | 4156 |
|
|
2024
Q4 | $34.6K | Hold |
3,192
| – | – | ﹤0.01% | 4167 |
|
|
2024
Q3 | $58.1K | Hold |
3,192
| – | – | ﹤0.01% | 4075 |
|
|
2024
Q2 | $90.9K | Hold |
3,192
| – | – | ﹤0.01% | 4033 |
|
|
2024
Q1 | $162K | Buy |
3,192
+1,385
| +77% | +$70K | ﹤0.01% | 3921 |
|
|
2023
Q4 | $103K | Buy |
+1,807
| New | +$85.5K | ﹤0.01% | 4049 |
|
|
2020
Q3 | – | Sell |
-77
| Closed | -$26K | – | 3858 |
|
|
2020
Q2 | $26K | Sell |
77
-839
| -92% | -$335K | ﹤0.01% | 3759 |
|
|
2020
Q1 | $943K | Buy |
916
+61
| +7% | +$89K | ﹤0.01% | 3317 |
|
|
2019
Q4 | $1.12M | Buy |
855
+110
| +15% | +$155K | ﹤0.01% | 3385 |
|
|
2019
Q3 | $1.03M | Buy |
745
+147
| +25% | +$237K | ﹤0.01% | 3387 |
|
|
2019
Q2 | $1.35M | Buy |
+598
| New | +$1.76M | ﹤0.01% | 3367 |
|
|
2018
Q4 | – | Sell |
-6
| Closed | -$14K | – | 3785 |
|
|
2018
Q3 | $14K | Sell |
6
-1
| -14% | -$2.4K | ﹤0.01% | 3752 |
|
|
2018
Q2 | $18K | Hold |
7
| – | – | ﹤0.01% | 3737 |
|
|
2018
Q1 | $16K | Hold |
7
| – | – | ﹤0.01% | 3725 |
|
|
2017
Q4 | $29K | Hold |
7
| – | – | ﹤0.01% | 3670 |
|
|
2017
Q3 | $30K | Sell |
7
-3
| -30% | -$12.8K | ﹤0.01% | 3700 |
|
|
2017
Q2 | $43K | Sell |
10
-155
| -94% | -$656K | ﹤0.01% | 3606 |
|
|
2017
Q1 | $903K | Buy |
165
+1
| +0.6% | +$4.66K | ﹤0.01% | 3289 |
|
|
2016
Q4 | $731K | Buy |
164
+16
| +11% | +$199K | ﹤0.01% | 3338 |
|
|
2016
Q3 | $3.1M | Buy |
148
+4
| +3% | +$72.4K | ﹤0.01% | 2802 |
|
|
2016
Q2 | $2.19M | Buy |
144
+5
| +4% | +$114K | ﹤0.01% | 2997 |
|
|
2016
Q1 | $3.88M | Sell |
139
-2
| -1% | -$42.3K | ﹤0.01% | 2682 |
|
|
2015
Q4 | $4.04M | Sell |
141
-479
| -77% | -$15.8M | ﹤0.01% | 2641 |
|
|
2015
Q3 | $15.4M | Buy |
620
+275
| +80% | +$18.5M | ﹤0.01% | 1926 |
|
|
2015
Q2 | $29.2M | Buy |
345
+89
| +35% | +$8.15M | ﹤0.01% | 1598 |
|
|
2015
Q1 | $26M | Buy |
256
+183
| +251% | +$24.4M | ﹤0.01% | 1660 |
|
|
2014
Q4 | $9.41M | Buy |
73
+31
| +74% | +$2.27M | ﹤0.01% | 2248 |
|
|
2014
Q3 | $2.02M | Buy |
42
+3
| +8% | +$105K | ﹤0.01% | 3010 |
|
|
2014
Q2 | $1.04M | Buy |
39
+7
| +22% | +$165K | ﹤0.01% | 3244 |
|
|
2014
Q1 | $835K | Buy |
32
+8
| +33% | +$227K | ﹤0.01% | 3279 |
|
|
2013
Q4 | $639K | Buy |
24
+6
| +33% | +$165K | ﹤0.01% | 3323 |
|
|
2013
Q3 | $533K | Buy |
18
+9
| +100% | +$319K | ﹤0.01% | 3339 |
|
|
2013
Q2 | $349K | Buy |
+9
| New | +$338K | ﹤0.01% | 3279 |
|
Other funds holding TPST
SM
VVM
TCM
State Street's TPST Position: Q2 2025 in Review
State Street sold out of Tempest Therapeutics (TPST) in Q2 2025, closing a stake of 3,192 shares — an estimated $30.6K sold.
State Street first reported a position in TPST in Q2 2013 and held it in 33 quarters. The position peaked at $29.2M in Q2 2015. 18 funds tracked by Wall St. Rank hold TPST as of Q2 2025.
- State Street reported no remaining Tempest Therapeutics position as of Q2 2025 after selling out during the quarter.
- State Street sold 3,192 Tempest Therapeutics shares in Q2 2025, an estimated $30.6K.
- State Street first reported a position in Tempest Therapeutics in Q2 2013 and held it in 33 quarters.
- State Street's Tempest Therapeutics position peaked at $29.2M in Q2 2015.
- 18 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2025.
Based on State Street's 13F filing for Q2 2025, filed 14 Aug 2025.